Nuvectis Pharma Statistics
NASDAQ: NVCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
19.71-0.585 (-2.88%)
Market open · Delayed 15 min · as of Oct 8, 11:47 AM ET
Nuvectis Pharma by the numbers
Nuvectis Pharma has a market capitalization of $643.3 million based on 32.64M shares outstanding. With trailing EPS of $-1.31, Nuvectis Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.7% below its 50-day average and 44.2% above its 200-day average.
Average daily trading volume is 217.91K shares, or about $4.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NVCT valuation vs. peer median
| Metric | NVCT | Peer median | Difference |
|---|---|---|---|
| Market cap | $643.25M | $658.43M | -2% |
| Avg. volume | 217.91K | 1.09M | -80% |
Peer median across 8 companies: ZVRA, WVE, OLMA, PHAR, ABUS, SGMT, FTH, AVTX.
Valuation
- Market cap
- $643.25M
- EPS (TTM)
- $-1.31
- Shares outstanding
- 32.64M
Price and trading
- Previous close
- 20.29
- Open
- 20.08
- Day range
- 19.67 – 20.35
- 52-week range
- 5.55 – 29.28
- 52-week change
- +232.08%
- Beta
- —
- Volume
- 58.39K
- Average volume
- 217.91K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 643.25M
- Forward Pe
- -20.53
- Eps
- -1.31
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 29.28
- Week52 Low
- 5.55
- Avg Volume
- 217.91K
- Shares Outstanding
- 32.64M
- Ma50
- 21.81
- Ma200
- 13.66
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -32.69%
- Pct From52w Low
- 255.05%